Clinical Trials Browser

Phase 2 × Withdrawn × Myasthenia Gravis × Clear all

NCT04982289 2022-02-11

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

Phase 2 Withdrawn

Myasthenia Gravis